ME, M., SA, B., EA, S., HB, W., ZS, Y., J, S., . . . AL, B. (2026). Genetics of Response to Canagliflozin (GRC) Study: Rationale, Design, and Pharmacodynamic Responses. Clinical and translational science, 19(6), e70594. https://doi.org/10.1111/cts.70594
Chicago Style (17th ed.) CitationME, Montasser, et al. "Genetics of Response to Canagliflozin (GRC) Study: Rationale, Design, and Pharmacodynamic Responses." Clinical and Translational Science 19, no. 6 (2026): e70594. https://doi.org/10.1111/cts.70594.
MLA (9th ed.) CitationME, Montasser, et al. "Genetics of Response to Canagliflozin (GRC) Study: Rationale, Design, and Pharmacodynamic Responses." Clinical and Translational Science, vol. 19, no. 6, 2026, p. e70594, https://doi.org/10.1111/cts.70594.